Innovative research at Cedars-Sinai has made it possible for people who are highly sensitized (have high antibodies to transplant targets) to successfully receive kidney transplants. Other research being done at Cedars-Sinai is helping to break down barriers of blood and tissue incompatibility.
In 1999, Cedars-Sinai received United Network for Organ Sharing certification for pancreas transplantation. Cedars-Sinai is one of a select few medical centers in Southern California performing kidney-pancreas transplants. Pancreas transplantation is used to prevent or reverse secondary complications of diabetes. The treatment is reserved for patients who are undergoing kidney transplantation and are also Type 1 Diabetic. Diabetic patients who have already undergone kidney transplantation are also candidates.
Dylan Worthen, 11
Ten years ago, Dylan became the youngest, smallest kidney transplant recipient ever at Cedars-Sinai. Today, he’s a healthy tween.Read Full Story
One third of patients awaiting kidney transplants are highly HLA-sensitized. The only option? Dialysis for life. That is, until recently...Learn More